Treatment options for hypertension in high-risk patients

研究成果: Review article同行評審

5 引文 斯高帕斯(Scopus)

摘要

Patients are considered to be at high risk of cardiovascular events if they have diabetes, chronic kidney disease, stroke, established coronary artery disease, or a coronary artery disease equivalent. Blood pressure-lowering therapy has been shown to reduce cardiovascular events in these patients significantly. Identification of high-risk patients by global risk evaluation is recommended for every hypertensive patient. Treatment of hypertension in high-risk patients with an angiotensin-converting enzyme inhibitor or an angiotensin receptor antagonist, with or without addition of a dihydropyridine calcium channel antagonist, is a reasonable approach based on current clinical trials.

原文English
頁(從 - 到)137-141
頁數5
期刊Vascular Health and Risk Management
7
發行號1
DOIs
出版狀態Published - 2011

All Science Journal Classification (ASJC) codes

  • 內分泌學、糖尿病和代謝
  • 血液學
  • 公共衛生、環境和職業健康
  • 心臟病學與心血管醫學
  • 藥學(醫學)

指紋

深入研究「Treatment options for hypertension in high-risk patients」主題。共同形成了獨特的指紋。

引用此